- Home
- API vs PRME Comparison
API vs PRME Comparison
Compare API & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- API
- PRME
- Stock Information
- Founded
- API 2013
- PRME 2019
- Country
- API United States
- PRME United States
- Employees
- API N/A
- PRME N/A
- Industry
- API Computer Software: Prepackaged Software
- PRME Medicinal Chemicals and Botanical Products
- Sector
- API Technology
- PRME Health Care
- Exchange
- API Nasdaq
- PRME Nasdaq
- Market Cap
- API 383.0M
- PRME 379.1M
- IPO Year
- API 2020
- PRME 2022
- Fundamental
- Price
- API $4.80
- PRME $2.89
- Analyst Decision
- API Strong Buy
- PRME Strong Buy
- Analyst Count
- API 1
- PRME 9
- Target Price
- API $6.00
- PRME $13.13
- AVG Volume (30 Days)
- API 829.5K
- PRME 1.1M
- Earning Date
- API 02-24-2025
- PRME 02-28-2025
- Dividend Yield
- API N/A
- PRME N/A
- EPS Growth
- API N/A
- PRME N/A
- EPS
- API N/A
- PRME N/A
- Revenue
- API $134,844,000.00
- PRME $800,000.00
- Revenue This Year
- API N/A
- PRME N/A
- Revenue Next Year
- API $5.50
- PRME $426.55
- P/E Ratio
- API N/A
- PRME N/A
- Revenue Growth
- API N/A
- PRME N/A
- 52 Week Low
- API $1.65
- PRME $2.56
- 52 Week High
- API $6.64
- PRME $9.77
- Technical
- Relative Strength Index (RSI)
- API 56.63
- PRME 45.80
- Support Level
- API $3.54
- PRME $2.63
- Resistance Level
- API $3.98
- PRME $2.92
- Average True Range (ATR)
- API 0.31
- PRME 0.22
- MACD
- API 0.05
- PRME 0.00
- Stochastic Oscillator
- API 91.78
- PRME 27.08
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.